Amass is launching v2 of its app, fundamentally rebuilt on top of its Core infrastructure of interconnected, semantically enriched life science datasets.

Amass is a scientific intelligence platform for R&D and business development teams in biotech and pharma. We help teams evaluate scientific claims, map competitive landscapes, and make better decisions across pipelines and external opportunities. The platform analyzes publications, patents, clinical trials, regulatory data, and internal sources such as ELNs and company datasets to generate structured, evidence-based insights. Common use cases include: • Scientific due diligence • Pipeline and target evaluation • Competitive intelligence • Literature review and evidence synthesis Used by teams across pharma, biotech, and life science investors. Available as SaaS, API, and enterprise integrations into internal R&D workflows.